Business PR Newswire iOncologi Secures Foundational U.S. Patent as Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival with Cancer Immunotherapy rvrisingnetwork October 21, 2025 0 Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi’s Universal Immune Fortifying RNAs... Read More Read more about iOncologi Secures Foundational U.S. Patent as Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival with Cancer Immunotherapy
